Mitsubishi UFJ Asset Management Co. Ltd. Purchases Shares of 11,875 Inspire Medical Systems, Inc. $INSP

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 11,875 shares of the company’s stock, valued at approximately $530,000.

A number of other institutional investors and hedge funds have also made changes to their positions in INSP. CWM LLC raised its holdings in Inspire Medical Systems by 216.1% in the fourth quarter. CWM LLC now owns 354 shares of the company’s stock valued at $33,000 after acquiring an additional 242 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Inspire Medical Systems by 1,115.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock worth $33,000 after acquiring an additional 580 shares in the last quarter. Havemeyer Place LP acquired a new position in Inspire Medical Systems during the 4th quarter worth approximately $39,000. Smartleaf Asset Management LLC increased its position in shares of Inspire Medical Systems by 84.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after purchasing an additional 205 shares during the last quarter. Finally, Versant Capital Management Inc increased its position in shares of Inspire Medical Systems by 379.0% in the 2nd quarter. Versant Capital Management Inc now owns 958 shares of the company’s stock valued at $43,000 after purchasing an additional 758 shares during the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Mizuho lifted their price objective on shares of Inspire Medical Systems from $55.00 to $65.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 4th. KeyCorp reissued a “sector weight” rating on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Wells Fargo & Company cut their price target on Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 5th. Piper Sandler lifted their price target on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Finally, Evercore set a $54.00 price target on Inspire Medical Systems in a report on Tuesday, August 4th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $66.19.

Insider Activity at Inspire Medical Systems

In other news, insider Jason P. Kelly sold 963 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the sale, the insider directly owned 18,985 shares of the company’s stock, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.20% of the company’s stock.

Inspire Medical Systems Price Performance

Shares of NYSE:INSP opened at $62.45 on Friday. The company’s fifty day moving average price is $51.14 and its 200 day moving average price is $52.77. Inspire Medical Systems, Inc. has a 12 month low of $38.91 and a 12 month high of $147.03. The firm has a market capitalization of $1.81 billion, a P/E ratio of 13.52, a P/E/G ratio of 4.74 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The firm had revenue of $200.58 million during the quarter, compared to analysts’ expectations of $194.72 million. During the same period in the previous year, the company earned $0.45 earnings per share. Inspire Medical Systems’s quarterly revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.